REG - PI Industries Ltd. - Rule 19.6(c) Confirmation
THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") WHICH, AMONGST OTHER THINGS, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF A PERIOD OF 12 MONTHS FROM THE DATE ON WHICH AN OFFER PERIOD ENDED CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS
20 August 2025
PI INDUSTRIES MANAGEMENT CONSULTANCIES L.L.C.
("Bidco")
Rule 19.6(c) confirmation with respect to post-offer intentions regarding Plant Health Care Limited (formerly Plant Health Care plc) ("PHC")
Bidco announces that, further to the completion of its recommended cash acquisition of the entire issued and to be issued ordinary share capital of PHC , which was effected by way of a scheme of arrangement under Part 26 of the Companies Act 2006 and became effective on 20 August 2024, it has duly confirmed in writing to The Panel on Takeovers and Mergers that in accordance with the requirements of Rule 19.6(c) of the Code that Bidco has complied with its post-offer statements of intent made pursuant to Rules 2.7(c)(viii) and 24.2 of the Code, as originally detailed in the Rule 2.7 announcement dated 26 June 2024 and the scheme document published on 10 July 2024.
Enquiries:
Zeus (financial adviser to Bidco and PI) | Tel: +44 20 3829 5000 |
Nick Cowles James Edis Louisa Waddell |
Important Notice
Zeus Capital Limited ("Zeus"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for PI and Bidco as financial adviser and no one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than PI and Bidco for providing the protections afforded to clients of Zeus, or for providing advice in relation to the matters referred to in this announcement. Neither Zeus nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Zeus in connection with the matters referred to in this announcement, any statement contained herein or otherwise.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END OUPSEWFISEISEEA